Aurobindo, Hetero, and Vivimed Class Action Settlements in Washington
Aurobindo, Hetero, and Vivimed class action settlements that covered Washington residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Washington residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Washington Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Washington
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Washington residents affected by contaminated blood pressure medications from pharmaceutical manufacturers Aurobindo, Hetero, and Vivimed may be eligible for compensation through the $15.2 million valsartan, losartan, and irbesartan class action settlement. Washington's Consumer Protection Act provides additional safeguards beyond federal regulations, allowing residents to seek damages for deceptive practices in pharmaceutical manufacturing and distribution. These companies supply generic medications widely distributed through Washington's major pharmacy chains including Walgreens, CVS, and regional pharmacies throughout Seattle, Spokane, and Tacoma metro areas. Washington residents filing class action claims must be aware that the state follows federal court procedures for multi-district litigation, meaning most pharmaceutical class actions are consolidated in federal courts outside Washington. The contaminated medications contained NDMA and other carcinogenic impurities that exceeded FDA safety limits. Washington's three-year statute of limitations for product liability claims may affect eligibility, though discovery rules can extend filing deadlines. Residents who purchased affected medications between 2012-2019 should gather pharmacy records and prescription documentation to support their claims in the settlement process.
Aurobindo, Hetero, and Vivimed Settlements in Washington: FAQs
Are Washington residents eligible for the Aurobindo, Hetero, and Vivimed valsartan settlement?
Yes, Washington residents who purchased contaminated valsartan, losartan, or irbesartan medications from these manufacturers between 2012-2019 are eligible for the $15.2 million settlement. You must provide pharmacy records showing purchase of affected medications containing NDMA or other carcinogenic impurities.
How does Washington's Consumer Protection Act affect pharmaceutical class action claims?
Washington's Consumer Protection Act allows residents to seek additional damages beyond federal remedies for deceptive pharmaceutical practices. This state law provides extra protection when manufacturers fail to disclose contamination risks in medications distributed through Washington pharmacies.
What documentation do Washington residents need for Aurobindo, Hetero, and Vivimed claims?
Washington residents need prescription records, pharmacy receipts, and medical records showing use of contaminated valsartan, losartan, or irbesartan medications. Contact your pharmacy directly for detailed prescription history, as Washington pharmacies are required to maintain these records for regulatory compliance.
Tips for Washington Residents Filing Aurobindo, Hetero, and Vivimed Claims
Washington residents filing Aurobindo, Hetero, and Vivimed claims should contact their pharmacy immediately to request complete prescription records for valsartan, losartan, and irbesartan medications purchased between 2012-2019. Gather all medical documentation showing adverse effects or cancer diagnoses potentially linked to contaminated medications. Submit claims before settlement deadlines, as Washington's statute of limitations may affect late filings. Consider consulting with Washington-licensed attorneys familiar with pharmaceutical class actions, as they understand state-specific consumer protection laws that may provide additional compensation beyond federal settlements. Keep detailed records of all medical expenses and treatments related to contaminated medication use for maximum settlement recovery.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
